The new Rapalog may lead to better Caloric Restriction mimestics
Researchers have developed a drug that targets mTOR, a pathway involved in aging. It could mimic caloric restriction and bring about similar health benefits.
The mTOR pathway
The mTOR pathway, also known as the mechanistic-target of rapamycin, is part of metabolism, and one of four major pathways which control it. Deregulated nutrient sense is the hallmark of aging, and affects all four pathways.
Source:
https://www.leafscience.org/new-rapalog-may-lead-to-better-caloric-restriction-mimetics/
